[ #NouveauMembre] - 📢Bienvenue CSafe un nouveau membre de MabDesign! CSafe offre la solution la plus complète pour le transport thermique des produits pharmaceutiques nécessitant une chaîne du froid à l'échelle mondiale. Avec une approche centrée sur le patient, une expertise approfondie du secteur et un engagement constant pour l'innovation, CSafe propose des produits de pointe dans les segments actifs et passifs. [ #NewMember]- 📢 Welcome to CSafe a new member of MabDesign! CSafe offers the most comprehensive solution for the thermal transport of pharmaceutical products requiring a cold chain on a global scale. With a patient-centric approach, in-depth industry expertise and a constant commitment to innovation, CSafe offers state-of-the-art products in both active and passive segments.
Post de MabDesign
Plus de posts pertinents
-
Thoughts on this? >> Biotheus builds on ADC pact with Hansoh; Novartis expands in Singapore; Astellas leaves Cartesian deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #biotech #healthcare #pharmaceutical
-
N'hésitez pas à aller échanger sur vos problématiques d'intégrité des données avec des experts du domaine Cédric MAUNOURRI et Joanna SINET d'Oravis. #dataintegrity #gxp
Nos experts seront présents au Forum Labo Lyon : Cédric MAUNOURRI et Joanna SINET 👉 N'hésitez pas à les contacter via le code QR #Forum #ForumLaboLyon #Pharma
-
-
Ce sera avec plaisir d'échanger sur les thématiques Qualité et amélioration continue 😉 #CSV #Dataintegrity #QMS
Nos experts seront présents au Forum Labo Lyon : Cédric MAUNOURRI et Joanna SINET 👉 N'hésitez pas à les contacter via le code QR #Forum #ForumLaboLyon #Pharma
-
-
* HALF YEAR REPORT * $LTP - LTR Pharma has today released its Half Year Financial Report for the period ended 31 December 2023. This has been a defining period for the Company, marked by a successful ASX debut on 11 December 2023 and rapid progress towards our pivotal bioequivalence study. Key highlights include: - Successfully completed an oversubscribed IPO. The Company listed on the ASX on 11 December 2023 and raised $7M - Presented SPONTAN intranasal spray clinical data to a global audience at the World Meeting on Sexual Medicine in Dubai - Key scientific and clinical adviser Professor Eric Chung honoured with the prestigious ISSN Tanagho Prize at the World Meeting on Sexual Medicine for the most innovative research - Completion of key milestones for its upcoming bioequivalence study, including commercial packaging studies and commencement of patient recruitment Read the Half Year Financial Report: https://t.co/HZUB8Glw8N $LTP #ASX #innovation #pharma #biotech #erectiledysfunction #menshealth
-
-
Apprenez-en plus sur le futur des produits pharmaceutiques ! Découvrez comment Getinge et West révolutionnent le transfert de composants stériles, des solutions de transfert pré-validées aux processus de transfert automatisés. Lire l’article https://lnkd.in/e7TN9SEA #Pharma #BioPharma #ProduitsPharmaceutiques
-
-
🎤 Live from Biosimilars LatAm - Europe 2024! 🌍✨ We're thrilled to highlight Erik's insightful session on "Cuban Perspectives on Biosimilar Regulation." 🏛️📜 📣 "There has always been an advisory system provided by CECMED. Consultations can be made prior to the submission of the dossiers, both during the acquisition and manufacturing stages of a new biosimilar, or after its production, to ensure that the registration process is as expedient and quick as possible." - Erik Perez Garcia His discussion sheds light on the robust #regulatoryframework in #Cuba, emphasizing the importance of pre- and post-production consultations to streamline biosimilar approvals. #Biosimilars #HealthcareRegulation #CubanInnovation #CECMED #BiosimilarsLatAm #Europe2024 #HealthcareAdvancements
-
-
Founder @ UberEvents.io | Omnichannel Marketing Strategy, CX, Product Launches, B2B/B2C Events
June's Controlled & Modified Drug Release / Bioavailability Enhancement program is viewable on the below link. 2024’s Summit themes include: - Long acting injectables - Solubilization approaches for parenteral routes of administration - Innovations in oral modified release technologies - Advances in oral delivery of peptides - PBPK Modeling to drive product development - Engineering prodrug therapies for infectious disease and cancer therapy - Excipients selection and understanding impact on oral drug bioavailability - Lipid-based formulations - Enhancing API bioavailability via nanotechnology for drug delivery - Innovations in targeted drug delivery mechanisms - Optimizing biologics product development - Improving oral bioavailability for poorly-soluble drug candidates - Patent-centric formulation approaches - Subcutaneous delivery - Advances wearable drug delivery systems And many more drug product development technologies and approaches.
June's 2024 Controlled & Modified Drug Release & Global Drug Bioavailability Enhancement Summit full program agenda is available here: https://lnkd.in/eNHi_7Q6 If you are tasked with developing modified release products, excipient selection, LAI, driving product optimization, patient-centric drug design, PBPK modeling, subcutaneous delivery, ASDs and much more, you won't want to miss this year's program. Some fantastic talks and special thanks to speakers: Joe Della Rocca, Aruna Railkar, Ph.D, PMP, Prajwal Thool, Seth Forster, Kellyn M. (Patros) Zagaja, Ph.D. , Jim Baxter, Girish Nihalani, Vivek Gupta, Mikhail Murashov, Siddharth (Sid) Kesharwani, M.S., Ph.D., Nicholas DiFranco, MEM, Indrajit Ghosh, Ph.D., MBA, Dipy Vasa, Ryan Pelis, Yongqian (Kelly) Zhang and many more. Special thanks to this year's sponsors and exhibitors; Serán BioScience, Glatt Group, Evonik, Quotient Sciences and The Lubrizol Corporation. If interested or planning to attend this June at the Hyatt Regency Princeton? Don't miss the earlybird registration rate with 3-for-2 group packs available also.
-
CQDM. On connecte. CQDM souhaite la bienvenue à nos 4 nouveaux Membres ''Réseau''! Nous sommes heureux d'accueillir DendroTEK Biosciences Inc., Neopharm Labs, sevenTM et RBCx. Nous vous invitons à en apprendre plus sur ces 4 nouveaux Membres ''Réseau'' via ce lien: https://lnkd.in/eu6EHW9k Le membership ''Réseau'' CQDM donne droit à plusieurs avantages qui facilitera votre réseautage, votre mise en contact et votre recherche de fonds pour votre recherche, tout en consolidant votre visibilité et votre impact dans l’écosystème de l’innovation biopharma. N'hésitez pas à devenir Membre ''Réseau'' également en cliquant le lien ci-dessous. Les frais sont de 150 $ par année, taxes incluses. Lien: https://lnkd.in/eu6EHW9k #lifesciences #biotechnology #drugdevelopment #innovation #funding #projects #medical #research #intelligenceartificielle #artificialintelligence #pharmaceutique #pharmaceutical #biopharma #biopharmaceutical #rna #rnatherapeutics #arn #faciliterinnovationbiopharma #membership #membres #avantages #advantages
-
-
CQDM. On connecte. CQDM souhaite la bienvenue à nos 4 nouveaux Membres ''Réseau''! Nous sommes heureux d'accueillir DendroTEK Biosciences Inc., Neopharm Labs, sevenTM et RBCx. Nous vous invitons à en apprendre plus sur ces 4 nouveaux Membres ''Réseau'' via ce lien: https://lnkd.in/e9dRFVz2 Le membership ''Réseau'' CQDM donne droit à plusieurs avantages qui facilitera votre réseautage, votre mise en contact et votre recherche de fonds pour votre recherche, tout en consolidant votre visibilité et votre impact dans l’écosystème de l’innovation biopharma. N'hésitez pas à devenir Membre ''Réseau'' également en cliquant le lien ci-dessous. Les frais sont de 150 $ par année, taxes incluses. Lien: https://lnkd.in/e9dRFVz2 #lifesciences #biotechnology #drugdevelopment #innovation #funding #projects #medical #research #intelligenceartificielle #artificialintelligence #pharmaceutique #pharmaceutical #biopharma #biopharmaceutical #rna #rnatherapeutics #arn #faciliterinnovationbiopharma #membership #membres #avantages #advantages
-
-
🎟️ CPHI Europe 📍🗺️ Fiera Milano, Italy 📅 8th - 10th of October 👥 John Moulding Giovanni Lucafò Are you heading to CPHI Europe in Milan this October? If so, make sure to speak to John Moulding and Giovanni Lucafo! They will be present at this year’s event and ready to discuss your products and materials to see where independent support from Alfred H Knight could support your organisation. With a wealth of experience in metals and minerals, we help clients determine the composition of their materials with accuracy and reliability. This enables them to extract maximum value and support a circular economy. For more information on this event or the range of services we provide, follow the link in the comments below. #pharmaceutical #recycling #reprocessing #circulareconomy
-
